GALXC Trademark

Trademark Overview

On Wednesday, February 17, 2021, a trademark application was filed for GALXC with the United States Patent and Trademark Office. The USPTO has given the GALXC trademark a serial number of 90531581. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, October 10, 2025. This trademark is owned by Dicerna Pharmaceuticals, Inc.. The GALXC trademark is filed in the Treatment & Processing of Materials Services, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of oligonucleotides

Biologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases and viral infections; drug delivery agents consisting of a biological compound in the form of a molecular complex that acts as a platform that facilitates delivery of ribonucleic acid RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies; oligonucleotide compounds for use in the targeted delivery of RNA interference (RNAi) therapy; oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for a wide range of medical purposes

Research and development of pharmaceutical products; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections
galxc

General Information

Serial Number90531581
Word MarkGALXC
Filing DateWednesday, February 17, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateFriday, October 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 16, 2024

Trademark Statements

Goods and ServicesCustom manufacture of oligonucleotides
Goods and ServicesBiologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases and viral infections; drug delivery agents consisting of a biological compound in the form of a molecular complex that acts as a platform that facilitates delivery of ribonucleic acid RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies; oligonucleotide compounds for use in the targeted delivery of RNA interference (RNAi) therapy; oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for a wide range of medical purposes
Pseudo MarkGALAXY
Goods and ServicesResearch and development of pharmaceutical products; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, May 19, 2021
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 19, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDicerna Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameDicerna Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Saturday, February 20, 2021NEW APPLICATION ENTERED
Thursday, February 25, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 25, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 25, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 27, 2021NON-FINAL ACTION E-MAILED
Wednesday, May 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 20, 2021ASSIGNED TO EXAMINER
Tuesday, July 27, 2021NON-FINAL ACTION WRITTEN
Tuesday, July 27, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 12, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 12, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 31, 2021SUSPENSION LETTER WRITTEN
Tuesday, August 31, 2021LETTER OF SUSPENSION E-MAILED
Tuesday, August 31, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, January 5, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 5, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 7, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, May 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 7, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, February 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 6, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, May 11, 2023NON-FINAL ACTION WRITTEN
Thursday, May 11, 2023NON-FINAL ACTION E-MAILED
Thursday, May 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 10, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, August 10, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, November 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 12, 2024SOU EXTENSION 1 FILED
Thursday, September 12, 2024SOU EXTENSION 1 GRANTED
Friday, October 10, 2025ABANDONMENT - NO USE STATEMENT FILED
Friday, October 10, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, September 12, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

galxc delivery diseases pharmaceutical oligonucleotide agents consisting drug compounds therapies wide